NCT01429051 - A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Break Through PainCancer

Interventions

DRUG

Intranasal Fentanyl Spray (INFS)

Applied as 1 puff (= 1 dose) in one nostril, or applied as two puffs (= 2 doses, 1 in each nostril) with ten minutes apart.

DRUG

Placebo

Matching intranasal placebo spray

Trial Locations (11)

Budapest

Debrecen

Kazincbarcika

Nyíregyháza

Pécs

Drammen

Trondheim

Moscow

Saint Petersburg

Smolensk

Yaroslavl